Bausch Health Companies | VRX - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Bausch Health Companies

Bausch Health Companies Inc reported $458M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.


Pre Tax Profit Change
Catalent CTLT:US USD 167M 111M
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Prestige Brands PBH:US USD -299522000 367.64M
Revance Therapeutics RVNC:US USD -59793000 86.16M
Supernus Pharmaceuticals SUPN:US USD 9.02M 26.12M